Explore scientific data around our next generation products. Use the filters below to narrow things down, or simply search via keyword.
Driving Tobacco Harm Reduction Real-World Outcomes with blu Electronic Vaping Product CORESTA
ViewAn approach to toxicological risk assessment for MOND flavours CORESTA
ViewHigh Content Screening of Tobacco Free Nicotine Pouch extracts shows marked reductions in Toxicity when compared to cigarette smoke extracts CORESTA
ViewPuffing Topography of PULZE Heated Tobacco and Heated Herbal Products Reveals Consistent Use Patterns that Support THR CORESTA
ViewDisposable E-Vapour Products Exhibit Lower in vitro toxicological Activity Than Cigarettes EUROTOX 2025
ViewEvaluation of high nicotine oral products shows potential to reduce tobacco related harm by offering satisfying alternatives
ViewA Toxicological Risk Assessment Strategy for the Responsible Development of NGP EUROTOX 2025
ViewTobacco-Free Nicotine Pouches Nicotine Release Profile can be Used to Estimate User Exposure A Comparative Analysis of In Vitro Dissolution and In Vivo Pharmacokinetics
ViewAssessment of a range of NGP using ToxTracker® and ToxProfilerTM MAX assays reveal marked reductions in biological activity compared to a cigarette EUROTOX 2025
ViewOrgan-on-a-chip modelling of early atherosclerosis events reveals reduced activity of e-vapour products compared to cigarettes
View
